Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
lead candidate selection
Description:
Lead candidate selection is the process of choosing promising drug-development compounds for further testing and development.
Related topics:
Computational Drug Discovery Methods (18%),
Monoclonal and Polyclonal Antibodies Research (14%),
Animal testing and alternatives (8%),
Protein purification and stability (7%)
OpenAlex ID:
keywords/lead-candidate-selection
Weak Interactions Govern the Viscosity of Concentrated Antibody Solutions: High-Throughput Analysis Using the Diffusion Interaction Parameter
2012
·
Brian D. Connolly
, Chris Petry
, et al.
·
Biophysical Journal
·
364
PDF
Pharmaceutical profiling in drug discovery
2003
·
E Kerns
, Li Di
·
Drug Discovery Today
·
334
Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery
2008
·
T P Barros
, W K Alderton
, et al.
·
British Journal of Pharmacology
·
317
PDF
Developability Assessment During the Selection of Novel Therapeutic Antibodies
2015
·
Alexander Jarasch
, Hans Koll
, et al.
·
Journal of Pharmaceutical Sciences
·
276
Making Better Drugs: Decision Gates in Non-Clinical Drug Development
2003
·
J. Fred Pritchard
, Malle Jurima-Romet
, et al.
·
Nature Reviews Drug Discovery
·
275
The Rule of Five Revisited: Applying Log D in Place of Log P in Drug-Likeness Filters
2007
·
Sanjivanjit K. Bhal
, Karim Kassam
, et al.
·
Molecular Pharmaceutics
·
261
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
2016
·
Dheeraj S. Tomar
, Sandeep Kumar
, et al.
·
mAbs
·
237
PDF
A Design-to-Device Pipeline for Data-Driven Materials Discovery
2020
·
Jacqueline M. Cole
·
Accounts of Chemical Research
·
127
Application of formulation technologies in lead candidate selection and optimization
2004
·
Mahesh V. Chaubal
·
Drug Discovery Today
·
89
Determining Partition Coefficient (Log P), Distribution Coefficient (Log D) and Ionization Constant (pKa) in Early Drug Discovery
2016
·
Sonali S. Bharate
, Vikas Kumar
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
88
High-throughput analysis of behavior for drug discovery
2015
·
Vadim Alexandrov
, Dani Brunner
, et al.
·
European Journal of Pharmacology
·
86
Optimizing the Hit-to-Lead Process Using SPR Analysis
2004
·
Stefan Löfås
·
Assay and Drug Development Technologies
·
71
Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process
2003
·
Alexander Alanine
, Matthias Nettekoven
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
67
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods
2021
·
Emily K. Makowski
, Lina Wu
, et al.
·
mAbs
·
64
PDF
Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery
2003
·
Chad L Stoner
, Adriaan Cleton
, et al.
·
International Journal of Pharmaceutics
·
63
Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection
2015
·
Alexandra Lavoisier
, Jean-Marc Schlaeppi
·
mAbs
·
59
PDF
Rapid assessment of drug metabolism in the drug discovery process
2000
·
Marc Bertrand
, Peter Jackson
, et al.
·
European Journal of Pharmaceutical Sciences
·
52
Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates
2017
·
Miroslav Dostalek
, Thomayant Prueksaritanont
, et al.
·
mAbs
·
49
PDF
A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life
2015
·
Colby A Souders
, Stuart C Nelson
, et al.
·
mAbs
·
46
PDF
Preclinical Development of Nononcogenic Drugs (Small and Large Molecules)
2016
·
J.B. Colerangle
·
Elsevier eBooks
·
45
InsectiPAD: A Web Tool Dedicated to Exploring Physicochemical Properties and Evaluating Insecticide-Likeness of Small Molecules
2019
·
Chen-Yang Jia
, Fan Wang
, et al.
·
Journal of Chemical Information and Modeling
·
44
An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities
2017
·
Bryan Koci
, Gregory Luerman
, et al.
·
Toxicology and Applied Pharmacology
·
41
Chaperone proteins as single component reagents to assess antibody nonspecificity
2017
·
Ryan L. Kelly
, James C. Geoghegan
, et al.
·
mAbs
·
36
PDF
Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
2012
·
Bin Chen
, Jennifer Q. Dong
, et al.
·
Current Pharmaceutical Biotechnology
·
34
Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery
2011
·
Adriana Alexandre S. Tavares
, James Lewsey
, et al.
·
Nuclear Medicine and Biology
·
31
Show more works
View as search
Works count:
116
Citation count:
3,725
Year
Topic
Type